Inspire Medical Systems (INSP) EBIT (2017 - 2026)

Inspire Medical Systems has disclosed EBIT across 10 years of filings, most recently posting -$1.1 million for Q1 2026.

• EBIT for Q1 2026 came in at -$1.1 million, up 24.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $51.3 million (up 3.02% YoY), and the FY2025 annual result was $51.0 million, up 41.21% from the prior year.
• EBIT came in at -$1.1 million for Q1 2026 at Inspire Medical Systems, down from $46.1 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $46.1 million in Q4 2025 to a low of -$19.5 million in Q1 2023.
• The 5-year median for EBIT is -$1.5 million (2025), against an average of -$114352.9.
• Across the five-year window, EBIT jumped 2875.22% in 2023 and plunged 165.03% in 2025, its largest moves.
• Inspire Medical Systems' EBIT stood at -$335000.0 in 2022, then surged by 2875.22% to $9.3 million in 2023, then soared by 242.95% to $31.9 million in 2024, then surged by 44.62% to $46.1 million in 2025, then sank by 102.42% to -$1.1 million in 2026.
• The last three EBIT figures came in at -$1.1 million (Q1 2026), $46.1 million (Q4 2025), and $9.6 million (Q3 2025), per Business Quant data.